Wedmont Private Capital

Source: SEC Form 13F · as of Mar 2026

Wedmont Private Capital holds 47 biotech & pharma companies tracked by BioSniper, totaling $81.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

47

Total value held

$81.4M

CompanySharesValue
LLYELI LILLY & Co14,822$14.1M
ABBVAbbVie Inc.43,207$9.1M
JNJJOHNSON & JOHNSON34,444$8.3M
PMPhilip Morris International Inc31,998$5.1M
GILDGILEAD SCIENCES, INC.32,777$4.6M
UNHUnitedHealth Group Incorporated Common Stock (DE)13,044$4.0M
RVMDREVOLUTION MEDICINES, INC.40,231$3.9M
MRKMerck & Co., Inc.25,861$3.2M
AMGNAMGEN INC8,435$3.0M
ABTABBOTT LABORATORIES27,899$2.9M
MCKMcKesson Corporation2,380$2.1M
IDXXIDEXX LABORATORIES INC /DE3,074$1.8M
VRTXVERTEX PHARMACEUTICALS INC / MA3,383$1.5M
PFEPFIZER INC51,735$1.4M
AZNASTRAZENECA PLC5,838$1.2M
NVSNovartis AG6,692$1.0M
BMYBRISTOL MYERS SQUIBB CO17,170$1.0M
CAHCardinal Health Inc.4,653$1.0M
UTHRUNITED THERAPEUTICS Corp1,669$971K
CORCencora Inc.2,896$941K
REGNREGENERON PHARMACEUTICALS, INC.1,198$929K
GMOptec International, Inc.12,006$921K
DGXQuest Diagnostics Incorporated3,034$603K
BIIBBIOGEN INC.2,908$523K
IONSIONIS PHARMACEUTICALS INC6,564$492K
BAXBaxter International Inc.28,535$492K
ELVElevance Health Inc.1,437$457K
WSTWest Pharmaceutical Services Inc.1,716$456K
JAZZJazz Pharmaceuticals plc2,303$451K
ROIVRoivant Sciences Ltd.15,817$446K
GEHCGE HealthCare Technologies Inc.5,519$407K
ALNYALNYLAM PHARMACEUTICALS, INC.1,222$400K
NVONovo Nordisk A/S10,586$398K
LQDALiquidia Corp9,343$357K
APLSApellis Pharmaceuticals, Inc.8,762$357K
RPRXRoyalty Pharma plc7,065$338K
DVADaVita Inc.1,972$293K
ELANElanco Animal Health Inc10,978$259K
MRNAModerna, Inc.4,549$237K
BMRNBIOMARIN PHARMACEUTICAL INC4,084$234K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)3,966$228K
NBIXNEUROCRINE BIOSCIENCES INC1,641$218K
CAICaris Life Sciences Inc.10,715$209K
VKTXViking Therapeutics, Inc.6,012$202K
SHCSotera Health Company11,143$170K
RXRXRECURSION PHARMACEUTICALS, INC.18,943$64K
OCGNOcugen, Inc.14,765$27K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Wedmont Private Capital — Biotech 13F Holdings & Portfolio | BioSniper